Cassava Paying $40 Million to Settle Doctored Alzheimer's Drug Data Claims 0 27.09.2024 03:55 The Wall Street Journal The Securities and Exchange Commission alleged that a researcher for the company manipulated trial data to make its drug results look more promising. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
